Pliant Therapeutics PLRX
NASDAQ PLRX
$1.15 +0.03 (+3.12%)
As of: Aug 21, 2026 · 10:53 AM EDT

Pliant Therapeutics (PLRX) Operating Margin Growth (3y) (2023)

Pliant Therapeutics (PLRX) Operating Margin Growth (3y) (2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.96 Bn 132.11 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 86.79 Bn 78.79 Bn 3.93 Bn -204.00
3 Argenx Se 65.22 Bn 60.03 Bn 1.37 Bn -537.00
4 Moderna 60.20 Bn 55.06 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 42.19 Bn 37.09 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 31.43 Bn 28.12 Bn 992.69 Mn 9,003.00
7 BioNTech SE 28.65 Bn 10.26 Bn 668.28 Mn -11,254.00
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 30,461.00
9 Royalty Pharma 27.16 Bn 26.32 Bn - -2,649.00
10 Pliant Therapeutics 71.52 Mn 71.52 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -1.86 Mn
Mar 31, 2023 -319,833.00